Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HAUS6P1 (HAUS augmin like complex subunit 6 pseudogene 1) is a human pseudogene named for its sequence homology to HAUS6, a component of the augmin complex involved in microtubule organization. Unlike its functional counterpart, HAUS6P1 does not encode a protein product and is classified under pseudogenes. According to gene nomenclature conventions, pseudogenes are incapable of producing functional proteins and typically do not serve as direct therapeutic targets or biomarkers. No disease associations, drug interactions, or safety concerns have been documented. The gene symbol and name are correct, but it should be annotated as a non-target for drug development, as its role is limited to potential noncoding regulatory effects with no substantial evidence for clinical or pharmacological significance.
None applicable. No mechanism of action exists for drugs targeting HAUS6P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HAUS augmin like complex subunit 6 pseudogene 1 (HAUS6P1).